advertisement
Abstract #82651 Published in IGR 20-4
Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement
Delgado MF; Abdelrahman AM; Terahi M; Miro Quesada Woll JJ; Gil-Carrasco F; Cook C; Benharbit M; Boisseau S; Chung E; Hadjiat Y; Gomes JAClinicoEconomics and outcomes research : CEOR 2019; 11: 591-604
Glaucoma is the leading cause of blindness in the developed and developing world. Not only is the clinical impact of this disease considerable, but associated economic and humanistic burdens - affecting patients, caregivers, and society - are substantial. Since glaucoma is an age-related disorder and populations in many developing countries are aging at a faster pace than in the developed world, increasing attention is being focused on ways to ameliorate the burdens of illness. In this paper, we examine the burdens of glaucoma with particular focus on developing countries, discuss some of the challenges that exist in delivering optimal glaucoma management within budget constraints, and bring into perspective how we could improve current healthcare systems, leverage technology, and strike an appropriate balance between cost and quality of care, thereby offering considerations to payors and policymakers in these countries that may result in longer-term cost savings, while concurrently striving to achieve the WHO Vision on the prevention of blindness and visual impairment.
Private Practice and Sociedad de Cirugía Ocular, Bogotá, Colombia.
Full articleClassification:
14 Costing studies; pharmacoeconomics